Monday

23rd Apr 2018

Drug supplies to EU crisis countries at risk, warn health analysts

  • Drug speculation threatens supplies, says GlobalData (Photo: Derek K. Miller)

Speculators are threatening the supply of medication to countries worst hit by the sovereign debt crisis, according to research by business analysts GlobalData.

GlobalData's report, published Wednesday (22 August) claimed that pharmacies in Greece and other South Mediterranean countries had cut drug prices in a bid to enable people to pay for their medicines.

Thank you for reading EUobserver!

Subscribe now for a 30 day free trial.

  1. €150 per year
  2. or €15 per month
  3. Cancel anytime

EUobserver is an independent, not-for-profit news organization that publishes daily news reports, analysis, and investigations from Brussels and the EU member states. We are an indispensable news source for anyone who wants to know what is going on in the EU.

We are mainly funded by advertising and subscription revenues. As advertising revenues are falling fast, we depend on subscription revenues to support our journalism.

For group, corporate or student subscriptions, please contact us. See also our full Terms of Use.

If you already have an account click here to login.

But theprice-cuts had led to speculators and wholesalers buying up medicines at knock-down prices in one member state and selling them in another.

GlobalData analyst Michael Leibfried, who asserted that drug companies in Europe were facing "renewed pricing pressure from all directions", described the practice as a "lucrative export carry trade" that was "shrinking prices in other countries due to reference pricing." The practice also threatens the supply of medicines to the EU's crisis-hit countries.

Although OECD figures suggest that European governments are still allocating 8-12% of public spending to healthcare, austerity budgets have already seen attempts by governments to cut back on drug bills, even in more prosperous countries.

Following the lead of the UK's National Institute for Clinical Excellence (Nice), which controls drug purchases for the NHS, the German government last year adopted legislation requiring drug companies to prove the price benefits of new medicines, in a move aimed at tightening costs for new medicines.

Under EU law national governments are solely responsible for negotiating drug prices with companies. However, GSK boss Andrew Witty, who also leads the European Federation of Pharmaceutical Industries and Associations (EFPIA), wants EU countries to agree to exclude bail-out countries from price referencing.

Last month the lobby group asked the EU commission to impose a temporary ban on drug re-exports, although this would breach internal market rules on the free movement of goods and services.

The EFPIA insists that drug companies made discounts and price-cuts worth €7 billion in 2010 and 2011 in the five countries Greece, Ireland, Italy, Portugal and Spain, accounting for 8 percent of the industry's turnover. They were also risking further multi-billion euro losses by making emergency plans to supply drugs to Greece, and other countries, in the event of them being forced out of the eurozone, Witty said.

Pharmaceutical giants are concerned that lower drug prices in crisis-hit countries are being used for benchmark pricing of drugs. Most member states base their medicine purchase prices on average prices across the EU.

Critics claim that the reference pricing scheme prevents companies charging over the odds for new drugs.

Meanwhile, drug giants also have fears about whether governments can pay their bills. In July, Swiss company Roche claimed that the five crisis euro countries owed €1.2 billion to settle unpaid drug bills. Figures collected by pharmaceuticals indicated that only 1 percent of drug sales to the Greek government had been paid for in the first three months of 2012.

IMF worried by social cost of Greek austerity

The Greek economy and its people are reaching the "limit" of what they can endure in terms of austerity cuts, a senior IMF official has said in unusually political remarks.

EU drugs regulator accused of being too cozy with Big Pharma

The European Parliament has refused to sign off on the accounts of the EU agency responsible for making sure all medicines in Europe are safe and effective for its citizens to use, accusing the body of being too close to Big Pharma.

EU takes step closer to 'posted workers' deal

Negotiators from the member states, EU Parliament and Commission reached a 'common understanding' to guarantee equal pay for equal work in the EU. They hope to reach a final agreement in June.

Magazine

A sustainable death wish

No one can escape death. But choices over how one's body is disposed of could either lessen or increase your carbon footprint.

News in Brief

  1. Audit office: Brexit 'divorce' bill could be billions higher
  2. MEPs urge better protection for journalists
  3. Dieselgate: MEPs back greater role for EU in car approvals
  4. European parliament adopts new organic farming rules
  5. EU granted protection to half million people in 2017
  6. Report: Facebook to carve 1.5bn users out of EU privacy law
  7. Greek court ruling permits migrants to travel to mainland
  8. Commonwealth summit hopes for trade boost after Brexit

Stakeholders' Highlights

  1. Nordic Council of MinistersWorld's Energy Ministers to Meet in Oresund in May to Discuss Green Energy
  2. ILGA EuropeParabéns! Portugal Votes to Respect the Rights of Trans and Intersex People
  3. Mission of China to the EUJobs, Energy, Steel: Government Work Report Sets China's Targets
  4. Martens CentreJoin Us at NET@WORK2018 Featuring Debates on Migration, Foreign Policy, Populism & Disinformation
  5. European Jewish CongressKantor Center Annual Report on Antisemitism Worldwide - The Year the Mask Came Off
  6. UNICEFCalls for the Protection of Children in the Gaza Strip
  7. Mission of China to the EUForeign Minister Wang Yi Highlights Importance of China-EU Relations
  8. Nordic Council of MinistersImmigration and Integration in the Nordic Region - Getting the Facts Straight
  9. Macedonian Human Rights MovementMacedonians in Bulgaria Demand to End the Anti-Macedonian Name Negotiations
  10. Counter BalanceThe EIB Needs to Lead by Example on Tax Justice
  11. ILGA EuropeTrans People in Sweden to be Paid Compensation for Forced Sterilisation
  12. International Partnership for Human RightsThe Danger of Standing Up for Justice and Rights in Central Asia

Latest News

  1. ECJ ruling set to end 10-year 'mouth tobacco' lobbying saga
  2. Whistleblowers, Syria and digital revolution This WEEK
  3. MEP friendship groups offer 'backdoor' for pariah regimes
  4. Macron and Merkel pledge euro reform
  5. Obscurity surrounds EU military fund's expert groups
  6. New EU party finance rules short circuit accountability
  7. Draghi to stay in secretive 'lobby' group
  8. Bulgaria offers lesson in tackling radical-right populists